Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Cash and Short-Term Investments

Aerie Pharmaceuticals Cash and Short-Term Investments Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Cash and Short-Term Investments from 2012 to 2020.
  • Aerie Pharmaceuticals Cash and Short-Term Investments for the quarter ending June 06, 2020 was $242m a -40.86% decrease of -99m year over year
  • Aerie Pharmaceuticals Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $242m a -40.86% decrease of -99m year over year
  • Aerie Pharmaceuticals Annual Cash and Short-Term Investments for 2019 was $309m a 34.40% increase of 106m from 2018
  • Aerie Pharmaceuticals Annual Cash and Short-Term Investments for 2018 was $203m a -23.09% decrease of -47m from 2017
  • Aerie Pharmaceuticals Annual Cash and Short-Term Investments for 2017 was $250m a 6.41% increase of 16m from 2016
Other Balance Sheet Metrics:
  • Aerie Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $309m a 6.12% increase of 19m year over year
  • Aerie Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $6m a 11.47% increase of 1m year over year
  • Aerie Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $269m a 49.51% increase of 133m year over year
View Chart On Koyfin

Quarterly AERI Cash and Short-Term Investments Data

06/2020$242m
03/2020$265m
12/2019$309m
09/2019$341m
06/2019$109m
03/2019$149m
12/2018$203m
09/2018$236m
06/2018$286m
03/2018$334m

Annual AERI Cash and Short-Term Investments Data

2019$309m
2018$203m
2017$250m
2016$234m
2015$137m
2014$140m
2013$70m
2012$3m
2011$15m